Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway

Nephrology Dialysis Transplantation

Volumn 27, Issue 1, 2012, Pages 81-89

  Shimada, Michiko ^a,b   Ishimoto, Takuji ^a   Lee, Pui Y ^c   Lanaspa, Miguel A ^a   Rivard, Christopher J ^a   Roncal Jimenez, Carlos A ^a   Wymer, David T ^c   Yamabe, Hideaki ^b   Mathieson, Peter W ^d   Saleem, Moin A ^d   Garin, Eduardo H ^c   Johnson, Richard J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b HIROSAKI UNIVERSITY   (Japan)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

CD80; corticosteroids; minimal change disease; Toll like receptor

Indexed keywords

ACTIN; B7 ANTIGEN; CATHEPSIN L; CXCL9 CHEMOKINE; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; MESSENGER RNA; SYNAPTOPODIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTRACELLULAR SIGNALING; MINIMAL CHANGE GLOMERULONEPHRITIS; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA;

ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD80; BLOTTING, WESTERN; CELLS, CULTURED; DENDRITIC CELLS; DEXAMETHASONE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIPOPOLYSACCHARIDES; NF-KAPPA B; PODOCYTES; POLY I-C; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 84863011163     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr271     Document Type: Article

References (24)

1. Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974; 2: 556-560
2. Reiser J, von Gersdorff G, Loos M et al. Induction of B7-1 in podo-cytes is associated with nephrotic syndrome. J Clin Invest 2004; 113: 1390-1397 (Pubitemid 39071694)
3. Garin EH, Diaz LN, Mu W et al. Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 2009; 20: 260-266
4. Garin EH, Mu W, Arthur JM et al. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 2010; 78: 296-302
5. Saleem MA, O'Hare MJ, Reiser J et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002; 13: 630-638 (Pubitemid 34183927)
6. Lanaspa MA, Giral H, Breusegem SY et al. Interaction of MAP17 with NHERF3/4 induces translocation of the renal Na/Pi IIa transporter to the trans-Golgi. Am J Physiol Renal Physiol 2007; 292: F230-F242 (Pubitemid 46105263)
7. Mundel P, Reiser J. Proteinuria: an enzymatic disease of the podocytes? Kidney Int 2010; 77: 571-580
8. Mason PD. Minimal change disease. In: Feehally J, Floege J, Johnson RJ, eds. Comprehensive Clinical Nephrology. Philadelphia: Mosby Elsevier; 2007: pp. 209-216
9. Hoebe K, Janssen EM, Kim SO et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 2003; 4: 1223-1229 (Pubitemid 37540691)
10. Kirou KA, Lee C, George S et al. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3958-3967 (Pubitemid 39643944)
11. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16: 3-9 (Pubitemid 38147427)
12. Der SD, Zhou A, Williams BR et al. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 1998; 95: 15623-15628 (Pubitemid 29018750)
13. Anders HJ, Schlondorff DO. Innate immune receptors and autophagy: implications for autoimmune kidney injury. Kidney Int 2010; 78: 29-37
14. Banas MC, Banas B, Hudkins KL et al. TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 2008; 19: 704-713
15. Robson MG. Toll-like receptors and renal disease. Nephron Exp Nephrol 2009; 113: e1-e7
16. Xing CY, Saleem MA, Coward RJ et al. Direct effects of dexametha-sone on human podocytes. Kidney Int 2006; 70: 1038-1045 (Pubitemid 44344073)
17. Schmid H, Henger A, Cohen CD et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003; 14: 2958-2966 (Pubitemid 37305659)
18. Srivastava T, Garola RE, Whiting JM et al. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int 2001; 59: 118-125 (Pubitemid 32055220)
19. Wornle M, Schmid H, Banas B et al. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 2006; 168: 370-385 (Pubitemid 43271137)
20. Pawar RD, Castrezana-Lopez L, Allam R et al. Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier. Immunology 2009; 128: e206-e221
21. Shimada M, Araya C, Ishimoto T et al. Minimal change disease: a "Two HIt" podocyte immune disorder? Pediatr Nephrol 2011; 26: 645-649
22. Yap HK, Cheung W, Murugasu B et al. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 1999; 10: 529-537 (Pubitemid 29117634)
23. Lai KW, Wei CL, Tan LK et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 2007; 18: 1476-1485
24. Araya C, Diaz L, Wasserfall C et al. T regulatory cell function in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2009; 24: 1691-1698